Schedule for 2018

 Date

 Course

Duration 

 Language

Registration deadline

28.05.-01.06.2018.

Programmatic introduction of the new and re-purposed anti-TB medicines for treatment of DR-TB

 5 days 

 Russian

 Closed

28.05.-01.06.2018.

LineProbe Assay technology -  rapid molecular drug susceptibility test available for the diagnosis of DR-TB

5 days 

 Russian

Closed

06.-15.08.2018.

Programmatic and clinical management of DR-TB in order to achieve sustainable development goals

 9 days

 English

 02.07.2018.

 

10.-19.09.2018.

 

Programmatic and clinical management of DR-TB in order to achieve sustainable development goals

 9 days

 Russian

 02.08.2018.

22.-26.10.2018.

Programmatic introduction of the new and re-purposed anti-TB medicines for treatment of DR-TB

 5 days

 Russian

 10.09.2018.

22.-26.10.2018.

LineProbe Assay technology - rapid molecular drug susceptibility test available forthe diagnosis of DR-TB

 5 days

 Russian

10.09.2018.

For registration please fill in the application form and return it by e-mail: liga.rusmane@aslimnica.lv.

 For more information, please contact course director Dr. Liga Kuksa (e-mail: liga.kuksa@aslimnica.lv) or course coordinator Ms. Liga Rusmane (e-mail: liga.rusmane@aslimnica.lv). 

WHO Collaborating Centre for Research and Training in Management of MDR-TB  TB and Lung Disease Centre of Riga East University hospital Tel. +371 67048246 


 .